World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
147
Citations
135283
World Ranking
1246
National Ranking
723

Overview

Daniel A. Haber is affiliated with Harvard University in the United States. Their research spans multiple fields within biomedical science, focusing primarily on medicine and biochemistry, genetics, and molecular biology. The scientist has contributed extensively to oncology, molecular biology, cancer research, pulmonary and respiratory medicine, and biomedical engineering.

Their research topics cover a broad range of cancer-related areas, including:

  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • Advanced Breast Cancer Therapies
  • Microfluidic and Bio-sensing Technologies
  • Lung Cancer Treatments and Mutations
  • RNA modifications and cancer
  • RNA Interference and Gene Delivery

Some of the recent significant publications by Daniel A. Haber include:

  • Integrating genomic features for non-invasive early lung cancer detection, 2020, Nature
  • Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis, 2020, Science
  • The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis, 2020, Cancer Discovery
  • Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells, 2020, Proceedings of the National Academy of Sciences
  • RNA transcripts stimulate homologous recombination by forming DR-loops, 2021, Nature

Frequent co-authors associated with Daniel A. Haber include:

  • Shyamala Maheswaran
  • Mehmet Toner
  • Taronish D. Dubash
  • Ben S. Wittner
  • Aditya Bardia

The scientist's work has been published repeatedly in several venues, reflecting their areas of focus. Frequent publication venues include:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research
  • Nature Communications
  • Proceedings of the National Academy of Sciences

Overall, Daniel A. Haber's research provides insights into various aspects of cancer biology and treatment, leveraging molecular biology techniques and diagnostic innovations, particularly in the context of lung and breast cancers. Their collaborations and scholarly output illustrate an interdisciplinary approach to addressing complex biomedical challenges.

Best Publications

  • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

    Thomas J Lynch;Daphne W Bell;Raffaella Sordella;Sarada Gurubhagavatula

  • DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

    Masaki Okano;Daphne W Bell;Daniel A Haber;En Li

  • Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    Eunice L. Kwak;Yung-Jue Bang;D. Ross Camidge;Alice T. Shaw

  • Isolation of rare circulating tumour cells in cancer patients by microchip technology.

    Sunitha Nagrath;Lecia V. Sequist;Shyamala Maheswaran;Daphne W. Bell;Daphne W. Bell

  • Epidermal growth factor receptor mutations in lung cancer

    Sreenath V. Sharma;Daphne W. Bell;Daphne W. Bell;Jeffrey Settleman;Daniel A. Haber

  • Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

    Wanjuan Yang;Jorge Soares;Patricia Greninger;Elena J. Edelman

  • Systematic identification of genomic markers of drug sensitivity in cancer cells

    Mathew J. Garnett;Elena J. Edelman;Sonja J. Heidorn;Christopher Greenman;Christopher Greenman

  • Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

    Min Yu;Aditya Bardia;Ben S. Wittner;Shannon L. Stott

  • hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization

    Matthew Meyerson;Christopher M Counter;Elinor Ng Eaton;Leif W Ellisen

  • Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

    Katherine M. Call;Thomas M Glaser;Caryn Y. Ito;Alan J. Buckler

  • Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

    Nicola Aceto;Aditya Bardia;David T. Miyamoto;Maria C. Donaldson

  • A Landscape of Pharmacogenomic Interactions in Cancer

    Francesco Iorio;Francesco Iorio;Theo A. Knijnenburg;Theo A. Knijnenburg;Daniel J. Vis;Graham R. Bignell

  • Detection of Mutations in EGFR in Circulating Lung-Cancer Cells

    Shyamala Maheswaran;Lecia V. Sequist;Sunitha Nagrath;Lindsey Ulkus

  • Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

    Raffaella Sordella;Daphne W. Bell;Daniel A. Haber;Jeffrey Settleman

  • Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

    Shannon L. Stott;Chia Hsien Hsu;Chia Hsien Hsu;Chia Hsien Hsu;Dina I. Tsukrov;Min Yu

  • Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

    Vasanthi S. Viswanathan;Matthew J. Ryan;Harshil D. Dhruv;Shubhroz Gill

  • Circulating tumor cells: approaches to isolation and characterization

    Min Yu;Shannon Stott;Mehmet Toner;Shyamala Maheswaran

  • Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

    Eunice L. Kwak;Raffaella Sordella;Daphne W. Bell;Nadia Godin-Heymann

  • Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

    Daphne W. Bell;Jennifer M. Varley;Tara E. Szydlo;Deborah H. Kang

  • Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells

    Emre Ozkumur;Ajay M. Shah;Jordan C. Ciciliano;Benjamin L. Emmink

Frequent Co-Authors

Shyamala Maheswaran
Shyamala Maheswaran Harvard University
Mehmet Toner
Mehmet Toner Harvard University
Jeffrey Settleman
Jeffrey Settleman Pfizer (Germany)
David T. Ting
David T. Ting Harvard University
Lecia V. Sequist
Lecia V. Sequist Harvard University
Sridhar Ramaswamy
Sridhar Ramaswamy Harvard University
Aditya Bardia
Aditya Bardia Harvard University
Miguel Rivera
Miguel Rivera Harvard University
Dennis C. Sgroi
Dennis C. Sgroi Harvard University
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering Medicine in the USA, many related degrees and alternative pathways can broaden your skills and career prospects. For healthcare professionals aiming to advance, affordable dnp programs offer flexible options to reach the highest level of nursing practice.

Those seeking entry into the nursing field may prefer a quicker route through a fast lpn program. These programs typically offer accelerated courses, allowing students to join the workforce sooner and start gaining invaluable hands-on experience.

Nurses with a Bachelor of Science in Nursing can enhance their credentials conveniently with bsn to np programs online. These programs are ideal for those who want to become Nurse Practitioners in specialized fields like psychiatric mental health, often with the flexibility of online study.

For those interested in the business and leadership side of healthcare, pursuing a health care administration degree online can open doors to management roles in hospitals, clinics, and beyond. Each of these options can complement or serve as alternatives to traditional medical degrees.

Best Scientists Citing Daniel A. Haber

Trending Scientists